MOBE

Biotechnology Research

Complex diseases can be cured by a new Gene-editing technology

By Journal Updates
24 May 2024

gene editing tool

MOBEs provide a new tool for disease modelling to researchers.

Discover More

Charles River Endosafe Cartridge Manufacturing Goes Fully Automated at Massachusetts Facility

CRDMO Business Healthcare & Pharmaceuticals News Technology

Charles River Endosafe Cartridge Manufacturing Goes Fully Automated at Massachusetts Facility

10 September 202610 September 2026

BiotechReality Business Intelligence Desk

Amgen: IMDELLTRA Imfinzi Combination Delivers Landmark Survival Gain in DeLLphi-305 Trial

Clinical Data Healthcare & Pharmaceuticals News Oncology

Amgen: IMDELLTRA Imfinzi Combination Delivers Landmark Survival Gain in DeLLphi-305 Trial

9 September 20269 September 2026

Clinical Trials & Data Desk

Semaglutide Childhood Obesity Trial Meets Primary Endpoint as Novo Nordisk’s STEP Young Study Shows 40.4% of Children No Longer Classified as Having Obesity

Clinical Data Anti-obesity Drugs Healthcare & Pharmaceuticals News Weight-loss Drugs

Semaglutide Childhood Obesity Trial Meets Primary Endpoint as Novo Nordisk’s STEP Young Study Shows 40.4% of Children No Longer Classified as Having Obesity

8 September 20268 September 2026

Clinical Trials & Data Desk

Novartis Pelacarsen Lp(a)HORIZON Trial Results: Phase III Study Misses Primary Cardiovascular Endpoint

Clinical Data Healthcare & Pharmaceuticals News

Novartis Pelacarsen Lp(a)HORIZON Trial Results: Phase III Study Misses Primary Cardiovascular Endpoint

7 September 20268 September 2026

Clinical Trials & Data Desk

IQVIA Predictive Clinical Development Cuts Trial Delays With AI-Powered Approach

Technology Clinical Trials CRO Healthcare & Pharmaceuticals News

IQVIA Predictive Clinical Development Cuts Trial Delays With AI-Powered Approach

6 September 20266 September 2026

BiotechReality Business Intelligence Desk

AstraZeneca Secures Etcamah Breast Cancer Approval in Combination With CDK4/6 Inhibitors for US Patients

News Healthcare & Pharmaceuticals Oncology Regulatory Approval

AstraZeneca Secures Etcamah Breast Cancer Approval in Combination With CDK4/6 Inhibitors for US Patients

6 September 20266 September 2026

Regulatory Intelligence Desk